Viorica Chelban,Matthew P Wilson,Jodi Warman Chardon,Jana Vandrovcova,M Natalia Zanetti,Eleni Zamba-Papanicolaou,Stephanie Efthymiou,Simon Pope,Maria R Conte,Giancarlo Abis,Yo-Tsen Liu,Eloise Tribollet,Nourelhoda A Haridy,Juan A Botía,Mina Ryten,Paschalis Nicolaou,Anna Minaidou,Kyproula Christodoulou,Kristin D Kernohan,Alison Eaton,Matthew Osmond,Yoko Ito,Pierre Bourque,James E C Jepson,Oscar Bello,Fion Bremner,Carla Cordivari,Mary M Reilly,Martha Foiani,Amanda Heslegrave,Henrik Zetterberg,Simon J R Heales,Nicholas W Wood,James E Rothman,Kym M Boycott,Philippa B Mills,Peter T Clayton,Henry Houlden,Care4Rare Canada Consortium and the SYNaPS Study Group,Yamna Kriouile,Mohamed El Khorassani,Mhammed Aguennouz,Stanislav Groppa,Blagovesta Marinova Karashova,Lionel Van Maldergem,Wolfgang Nachbauer,Sylvia Boesch,Larissa Arning,Dagmar Timmann,Bru Cormand,Belen Pérez-Dueñas,Gabriella Di Rosa,Jatinder S Goraya,Tipu Sultan,Jun Mine,Daniela Avdjieva,Hadil Kathom,Radka Tincheva,Selina Banu,Mercedes Pineda-Marfa,Pierangelo Veggiotti,Michel D Ferrari,Arn M J M van den Maagdenberg,Alberto Verrotti,Giangluigi Marseglia,Salvatore Savasta,Mayte García-Silva,Alfons Macaya Ruiz,Barbara Garavaglia,Eugenia Borgione,Simona Portaro,Benigno Monteagudo Sanchez,Richard Boles,Savvas Papacostas,Michail Vikelis,James Rothman,Paola Giunti,Vincenzo Salpietro,Emer Oconnor,Dimitri Kullmann,Rauan Kaiyrzhanov,Roisin Sullivan,Alaa Matooq Khan,Wai Yan Yau,Isabel Hostettler,Eleni Zamba Papanicolaou,Efthymios Dardiotis,Shazia Maqbool,Shahnaz Ibrahim,Salman Kirmani,Nuzhat Noureen Rana,Osama Atawneh,Shen-Yang Lim,Farooq Shaikh,George Koutsis,Marianthi Breza,Salvatore Mangano,Carmela Scuderi,Giovanna Morello,Tanya Stojkovic,Erin Torti,Massimi Zollo,Gali Heimer,Yves A Dauvilliers,Pasquale Striano,Issam Al-Khawaja,Fuad Al-Mutairi,Fowzan S Alkuraya,Hamed Sherifa,Mie Rizig,Njideka U Okubadejo,Oluwadamilola O Ojo,Olajumoke O Oshinaike,Kolawole Wahab,Abiodun H Bello,Sanni Abubakar,Yahaya Obiabo,Ernest Nwazor,Oluchi Ekenze,Uduak Williams,Alagoma Iyagba,Lolade Taiwo,Morenikeji Komolafe,Olapeju Oguntunde,Sofya Pchelina,Konstantin Senkevich,Nourelhoda Haridy,Chingiz Shashkin,Nazira Zharkynbekova,Kairgali Koneyev,Ganieva Manizha,Maksud Isrofilov,Ulviyya Guliyeva,Kamran Salayev,Samson Khachatryan,Salvatore Rossi,Gabriella Silvestri,Thomas Bourinaris,Georgia Xiromerisiou,Liana Fidani,Cleanthe Spanaki,Arianna Tucci

Abstract:Objective: To identify disease-causing variants in autosomal recessive axonal polyneuropathy with optic atrophy and provide targeted replacement therapy. Methods: We performed genome-wide sequencing, homozygosity mapping, and segregation analysis for novel disease-causing gene discovery. We used circular dichroism to show secondary structure changes and isothermal titration calorimetry to investigate the impact of variants on adenosine triphosphate (ATP) binding. Pathogenicity was further supported by enzymatic assays and mass spectroscopy on recombinant protein, patient-derived fibroblasts, plasma, and erythrocytes. Response to supplementation was measured with clinical validated rating scales, electrophysiology, and biochemical quantification. Results: We identified biallelic mutations in PDXK in 5 individuals from 2 unrelated families with primary axonal polyneuropathy and optic atrophy. The natural history of this disorder suggests that untreated, affected individuals become wheelchair-bound and blind. We identified conformational rearrangement in the mutant enzyme around the ATP-binding pocket. Low PDXK ATP binding resulted in decreased erythrocyte PDXK activity and low pyridoxal 5'-phosphate (PLP) concentrations. We rescued the clinical and biochemical profile with PLP supplementation in 1 family, improvement in power, pain, and fatigue contributing to patients regaining their ability to walk independently during the first year of PLP normalization. Interpretation: We show that mutations in PDXK cause autosomal recessive axonal peripheral polyneuropathy leading to disease via reduced PDXK enzymatic activity and low PLP. We show that the biochemical profile can be rescued with PLP supplementation associated with clinical improvement. As B6 is a cofactor in diverse essential biological pathways, our findings may have direct implications for neuropathies of unknown etiology characterized by reduced PLP levels. ANN NEUROL 2019;86:225-240.

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Biallelic mutations in sord are a common cause of potentially treatable genetic neuropathy

Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Elevated sorbitol underlies a heritable neuropathy

SORD-deficient rats develop a motor-predominant peripheral neuropathy unveiling novel pathophysiological insights

Clinical and Genetic Features of Biallelic Mutations in SORD in a Series of Chinese Patients With Charcot-Marie-Tooth and Distal Hereditary Motor Neuropathy

Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement

Biallelic Mutations in the Ferredoxin Reductase Gene Cause Novel Mitochondriopathy with Optic Atrophy

Biallelic SORD pathogenic variants cause Chinese patients with distal hereditary motor neuropathy

A medical odyssey of a 72‐year‐old man with Charcot–Marie–Tooth disease type 2 newly diagnosed with biallelic variants in SORD gene causing sorbitol dehydrogenase deficiency

Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy

Evaluation of SORD mutations as a novel cause of Charcot‐Marie‐Tooth disease

Biallelic variants in ARHGAP19 cause a motor-predominant neuropathy with asymmetry and conduction slowing

Exploratory analysis of lower limb muscle MRI in a case series of patients with SORD neuropathy

Insulin-regulated serine and lipid metabolism drive peripheral neuropathy

Distal hereditary motor neuropathies: Mutation spectrum and genotype-phenotype correlation

Juvenile amyotrophic lateral sclerosis associated with biallelic c.757delG mutation of sorbitol dehydrogenase gene

PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation

Skeletal muscle involvement in biallelic SORD mutations: case report and review of the literature

A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes

Generation of 3 patient induced Pluripotent stem cell lines containing SORD mutations linked to a recessive neuropathy